Anti-viral compounds
Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.
AbbVie Inc.
A C C C C C C A C A C C A A C C C C C C A C
A61P C07D C07C C07D C07D C07D C07D A61P C07C A61P C07C C07D A61P A61P C07D C07D C07F C07K C07D C07D A61P C07D
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
John K. Michael D. Warren M. Sachin V. Dachun David A. Charles W. David A. John T. Pamela L. Mark A. Allan C. Rolf Mary E. Charles A. Clarence J. Douglas K. Seble H. Tammie K. Daniel D. Christopher E. Kevin R. Todd W. Lissa T. Kathy Ryan G. Wenke Yi Jean C.
Pratt Tufano Kati Patel Liu DeGoey Hutchins Betebenner Randolph Donner Matulenko Krueger Wagner Bellizzi Flentge Maring Hutchinson Wagaw Jinkerson Caspi Motter Woller Rockway Nelson Sarris Keddy Li Gao Califano